CA Healthcare Acquisition Corp.
CAHC · Nasdaq
NO ACTION REQUIRED
Nothing left to do
The purchase completed and the shares became shares in the company it bought. There is no deadline left to miss.
Cash at settlement
No cash-per-share figure was filed for this vehicle before it finished.
Last close
Daily close
No price history on file yet — daily closes accumulate from the market data feed.
Trust settled · There is no line to draw here. This vehicle has finished: the cash was paid back or spent closing the deal, so the last filed figure describes an account that no longer exists and would be a floor under nothing.
SpacBrain’s read
Trust settled
The deal closed — SPAC shares became the target's shares, so there is no trust left to redeem (nobody missed a window; holders who wanted cash elected it at the vote).
In plain terms
- What it is
- A SPAC from CA Healthcare Sponsor LLC, listed on Nasdaq in January 2021.
- What it's doing now
- It agreed to buy LumiraDx Limited, a point-of-care diagnostics company. That purchase completed, and it stopped being a SPAC — the shares became shares in the business it bought.
- What you should know
- This SPAC has finished. The purchase completed, and the shares became shares in the company it bought — anyone who wanted the cash instead asked for it at the vote, so there is no cash left here to claim and no deadline left to miss.
At a glance
- Where it stands
- Closed (deSPAC)
- The business it bought
- LumiraDx Limited
- Industry
- Health Care — point-of-care diagnostics
- Deal value
- not stated in the filings we hold
- Price vs cash at settlement
- no live price on file
- Cash in trust when it settled
- not yet extracted into a snapshot — the filings below may state it
- the last trust total filed while this was still a SPAC — the account has since been paid out or used to close the deal
- IPO
- 27 January 2021
- size not on file · 100.0% of each $10 unit into trust
- Headquarters
- 99 SUMMER STREET SUITE 200, BOSTON, MA, 02110
- registered in Delaware
- Lead underwriter
- not extracted from the prospectus yet
- Key officers
- Neiterman Larry J (Chief Executive Officer) · Naimollah Afsaneh (Director) · McMahon Timothy J
- Listed securities
- CAHC common
This vehicle has finished, so there is no window to file a cash-per-share figure for and none will follow. No estimate is shown in its place.
Nothing dated is on file. That is an absence in the record, not a statement that nothing is coming.
Yield to redemption
Nothing left to redeem — no yield to compute.
This SPAC has finished — its trust was paid back or used to close the deal, so there is nothing left to redeem and no yield to compute. A yield to redemption is a claim that you can hand these shares back for the trust cash. That account is closed, so this page will not print a number here.
What happened to the cash
The reasoning behind the verdict above, in the order the filings establish it.
- The deal closed — SPAC shares became the target's shares, so there is no trust left to redeem (nobody missed a window; holders who wanted cash elected it at the vote).
What has happened, and what is coming
1 dated milestoneEvery dated step from the day it listed to the next date you may have to act on. Where you have to do something, the day your broker needs the instruction is marked too.
- 27 January 2021IPOpassed
IPO size not on file
The deal
terms as filedWhat it is buying, on what terms, and how much of the combined company new shares take from you.
- closedHealth CareSEC primaryDeal structureSEC-primary — BCA 8-K / S-4 / DEFM14A
- PIPE
- ≈ $300M · unsourced
- Min-cash condition
- $65M
PIPE terms — instrument, coupon, conversion price and any reset floor — are not sourced for this deal. The size above is itself unsourced — a stored figure no filing we hold states — so neither the size nor the terms should be read as cited.
The score
deterministic, from filed fieldsCAHC is not in the scored universe, so no score is shown. A withheld score is a fact about the record, not a verdict about the company.
The score is only published for names that carry both a price and a filed cash-per-share figure — 292 of the tracked fleet today. The rest keep an empty dial rather than a modelled one, and fill in by themselves as the fields land.
The company
from SEC filingsRead the full profile
CA Healthcare Acquisition Corp. (CAHC) was a blank-check company listed on the Nasdaq Stock Market under SEC CIK 0001832352. The company priced its initial public offering on January 27, 2021, per 424B prospectus 0001104659-21-008264. The common ticker CAHC appeared on the cover page of 8-K 0001104659-21-120367, filed on September 29, 2021. The vehicle completed a business combination and no longer files, with 8-K 0001104659-21-122551 filed on October 4, 2021, reporting that a change in control of CAH occurred and CAH became a wholly owned subsidiary of LumiraDx following the consummation of the merger.
Material findings
from the full read of every filingEvery document this company files gets read whole — body and exhibits. These are the ones the read flagged as material, newest first, each citing its filing.
Economics and votes are deliberately separated. Assuming no redemptions, CAH's public holders end up with 4.4% of the share capital but only about 0.5% of the voting power, and the sponsor with 1.3% and about 0.2%, because LumiraDx's existing holders keep LMDX ordinary shares carrying ten votes each while the SPAC's side receives one-vote common shares. Existing shareholders other than management hold 65.4% of the capital and about 70.1% of the votes. The sponsor also exchanges 4,050,000 private placement warrants for 405,000 LMDX common shares.
Filings
live EDGAR feedEverything this company has filed with the SEC recently, newest first, each with a plain summary of what changed and why it matters.
Show the other 10 filings
What changed: CA Healthcare Acquisition Corp. issued definitive merger materials, a combined proxy statement and prospectus, on the Agreement and Plan of Merger dated April 6, 2021, as amended August 19, 2021 and further amended August 27, 2021, with LumiraDx Limited and LumiraDx Merger Sub, Inc. Merger Sub merges into CAH, which survives as a wholly owned subsidiary of LumiraDx. The prospectus covers up to 14,780,000 LMDX common shares, 5,750,000 LMDX warrants and the 5,750,000 LMDX common shares underlying them. Why it matters: Economics and votes are deliberately separated. Assuming no redemptions, CAH's public holders end up with 4.4% of the share capital but only about 0.5% of the voting power, and the sponsor with 1.3% and about 0.2%, because LumiraDx's existing holders keep LMDX ordinary shares carrying ten votes each while the SPAC's side receives one-vote common shares. Existing shareholders other than management hold 65.4% of the capital and about 70.1% of the votes. The sponsor also exchanges 4,050,000 private placement warrants for 405,000 LMDX common shares.
outside datenothing moved · 1 with no prior record of ours
- Outside date
- no earlier filing2021-09-30
SpacBrain reads this as the agreement may be terminated from 2021-09-30.
The clause …“CAH or the Company if the Effective Time shall not have occurred prior to September 30, 2021 (the Outside Date ); provided , however , that this Agreement may not be terminated under this Section 8.1(b) by or on behalf of any”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
The sponsor
The people who set this company up, what they have done before, and the advisers around the deal.
CA Healthcare Sponsor LLCnamed as sponsor in this SPAC’s filings — but with no researched track record behind it yet.
A missing score, not a score of zero — why
A Sponsor Score is only published once the sponsor’s prior vehicles have been verified on EDGAR and their post-close outcomes priced. That record does not exist for this sponsor yet, so no number and no tier is shown. That is a missing score, not a score of zero — and not a neutral 50 either.
Coverage so far: 301 of 1283 tracked SPACs (23%) are attached to a scored sponsor. This card fills in by itself as the research lands.
The record
The reference detail — how the shares were structured at listing, how thinly they trade, and where the company is registered.
Show the reference detail
Unit structure
Unit: U = S + W/2 · 100.0% of the $10 unit
from 424B4 0001104659-21-008264
Trading & liquidity
Company profile
Directors & officers
- Neiterman Larry JChief Executive Officer
- Naimollah AfsanehDirector
- McMahon Timothy J10% owner
- LANG DAVID S BDirector
- Klein David HDirector
- Cibotti Thomas M10% owner
- Barnes Jeffrey HDirector
Institutional holders
from SC 13G/13DFunds that have declared a stake above 5%. Heavy ownership by arbitrage funds usually means heavy cash-outs at the next vote.
Show the declared stakes
2 filers with a stake on file · 0 re-affirmed in the last 12 months. A stake with no amendment since is the filer’s last word on it, not proof it is still held — and percentages filed in different years are percentages of different floats, because this vehicle’s share count collapses at every redemption.
- Senvest Management, LLCwith 1 other reporting person on the same schedule6.1% · SC 13GSep 24, 2021 stale
- INTEGRATED CORE STRATEGIES (US) LLCwith 4 other reporting persons on the same schedule0.0% · SC 13G/AFeb 14, 2022 stale
One line per filer, not per reporting person: a joint schedule names the management company, its funds and often the individual who controls them, and all of them report the same shares. Click a name for that filer’s whole footprint across every SPAC it has declared a stake in.
News
company wires and the financial pressReporting we have matched to this ticker. Headlines belong to the outlets that wrote them.
Show the headlines
- LumiraDx to Become Publicly Traded following Successful Closing of Merger with CA Healthcare Acquisition Corp.
Business Wireundated by the source
Sources on file
harvested pages, kept in fullEvery public page we have read about this company, stored in full so a source can never go missing.
Show the sources
35 full SEC filing texts archived — searchable, never lost.
- Vault note — CAHC (CA Healthcare Acquisition Corp.)
vault-note · /vault/tickers/CAHC
- Vault deal note — LumiraDx Limited (CAHC)
vault-note · /vault/deals/lumiradx-limited
- Ihre Datenschutzeinstellungen
news · consent.yahoo.com
In plain English
tap a term to open itEvery piece of jargon this page could have used, and what it actually means.
Open the plain-English guide
No floor / floorlessthe cash guarantee is gone — the price is unprotected
A SPAC's downside protection is not the cash in trust; it is your right to demand that cash. Once the redemption window closes, the cash stays with the company and the share can trade anywhere.
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Broker action datethe day your broker needs the instruction — earlier than the official date
Brokers batch redemption instructions to the transfer agent, so the practical cutoff is roughly two business days before the published deadline. This is the date that actually costs people the floor.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Trust discountbuying below the cash held for you
Only meaningful while a redemption right exists. On a floorless name the same arithmetic is not a discount, it is the market pricing distress, and this product will not call it a yield.
Dilutionhow much of the company new shares take from you
Sponsor promote, PIPE shares, warrants and rights all issue stock that did not pay $10 for it. The headline deal value is before that; the effective value is after.
Pro-forma equitywhat the company is valued at once the deal closes
The combined company's equity value assuming the announced terms and the redemptions that have actually happened.
ARShow much upside you get per unit of downside
SpacBrain's asymmetric-return score. It is deterministic — the same inputs always produce the same number — and it is capped, not zeroed, when the floor is gone.
De-SPACthe day the SPAC becomes the real company
The shares stop being a claim on a pot of cash and start being equity in an operating business. Roughly 80% of recent de-SPACs traded below $10 within a year.
Outside datethe contractual long-stop for closing the deal
A deadline between the SPAC and its target, not between the SPAC and you. It confers no right to cash, which is exactly why it must never be counted as a redemption window.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.
Accreted NAV (estimate)the last filed cash figure, plus the interest it should have earned since
A model, not a filing: last filed value compounded at the 3-month T-bill for the days elapsed. Always shown in italic with the word estimate, and never printed beside a filed number without it.
Ask the brain
from its filingsData provenance & audit trail6 internal entries
Written by SpacBrain’s data agents whenever a figure is captured, corrected or flagged, and kept verbatim so every number on this page can be traced back to the filing that states it. This is a running log, not the current record: an early entry may be superseded by a later correction — the panels above always hold the current values.
admitted from the HISTORICAL census (EDGAR's SIC 6770 registrant list, walked in full: 3,325 registrants, 1,167 of which ever priced an IPO). The live discovery job cannot reach this registrant — it reads the filing tape, and this one stopped filing. Admission rule: src/lib/universe-admit.ts. SIC 6770 (Blank Checks); 424B 0001104659-21-008264 priced 2021-01-27; common ticker CAHC off 8-K 0001104659-21-120367 (2021-09-29); lifecycle EXITED. Ending PROVEN, not inferred: CLOSED per 8-K 0001104659-21-122551 (2021-10-04) — tem 5.01. As a result of the consummation of the Merger, a change in control of CAH occurred. Following the consummation of the Merger, CAH became a wholly owned subsidiary of LumiraDx. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. The information set forth in the Introductory Note and It. ipoSizeM and deadline left NULL: gross-proceeds prose conflates the over-allotment with the offering, and a charter deadline belonging to a vehicle that has ended is a date nobody can act on. ipoDate is the 424B pricing date.
sponsor "CA Healthcare Sponsor LLC" sourced from prospectus definition (424B4) acc 0001104659-21-008264.
[CLOSED-2.01] SEC accession 0001104659-21-122551 (Form 8-K, item 2.01 Completion of Acquisition or Disposition of Assets); the cover's date of earliest event reported is 2021-09-28. That is the SEC's own date for this report and NOT necessarily the closing day — an 8-K may cover several events, and where the two differ the closing date is in the quoted sentence below. Target read STRUCTURALLY from the merger agreement's party list — the party that is neither the registrant (identified by the filing's own cover page) nor a merger sub (identified by the clause making it a subsidiary of another party) nor an accommodation party (identified by a "solely for purposes of" joinder), and it was the only one left. The sentence it was read from: "(" CAH "), a Delaware corporation, entered into an Agreement and Plan of Merger, dated as of April 6, 2021, as amended pursuant to the Amendment to the Agreement and Plan of Merger, dated August 19, 2021, as further amended pursuant to the Second Amendment to the Agreement and Plan of Merger, dated August 27, 2021 (the " Merger Agreement "), by and among CAH, LumiraDx Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (" LumiraDx "), and LumiraDx Merger Sub, Inc., a newly formed Delaware corporation and wholly owned subsidiary of LumiraDx (" Merger Sub ") ." No deal value is set — an item-2.01 heading is not a figure. No date column is set: Deal has announcedAt, voteDate and expectedCloseAt and nowhere to record an actual close, so the SEC's date is kept here until that column exists. [DEAL-STRUCTURE-MINED] pipeSizeM=300, minCashM=65 from primary filings (0001193125-21-265531, 0001104659-21-120367).
entity created from the filed target name; no About paragraph on file, so every other field awaits a sourced read
pipeBasis set to UNSOURCED: the size came from the research seed / an earlier record and no filing we hold states it — surfaces now label it "unsourced"; an LLM re-read to FILED replaces this when credits allow
OTHER -> HEALTHCARE, on 8-K 0001104659-21-122551: "CAH, the Company and LumiraDx Merger Sub, Inc., a Delaware corporation (“ Merger Sub ”), are parties to that certain Agreement and Plan of Merger, d"